Key result
EV-ICD implantation proves feasible and stable through 6 months in severe ankylosing spondylitis.
Why the study?
Severe thoracic deformity in ankylosing spondylitis complicates ICD implantation and device selection, requiring careful anatomical assessment and individualized procedural planning for EV-ICD implantation.
Case Report (n=1)
EV-ICD implantation is technically feasible and demonstrates stable performance over 6 months in a patient with severe ankylosing spondylitis and thoracic deformity when tailored planning and precise dissection are used.
May be feasible in severe ankylosing spondylitis with thoracic deformity; leaves open need for prospective studies before wider adoption.
Background Severe thoracic deformity in ankylosing spondylitis (AS) can complicate ICD implantation and device selection. Substernal EV-ICD implantation requires careful anatomical assessment and individualized procedural planning. Case Summary A 57-year-old male with severe AS and dilated cardiomyopathy was referred for primary prevention ICD implantation. Given the high complication risks associated with conventional approaches, EV-ICD was selected. A tailored positioning strategy was employed to accommodate the thoracic deformity. Intraoperative resistance during substernal dissection was successfully overcome through meticulous re-dissection. Favourable intraoperative electrical parameters were obtained, including an R-wave sensing amplitude of 5.6 mV without P-wave oversensing and successful defibrillation at 30 J on the first attempt. At 6-month follow-up, device performance remained stable without sensing anomalies or inappropriate shocks. Discussion This case demonstrates the technical feasibility of EV-ICD implantation in a carefully selected patient with severe AS-associated thoracic deformity. Preoperative CT assessment, tailored patient positioning, careful dissection, and surgical backup enabled successful implantation and stable device performance during 6 months of follow-up.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) conducted a case report in Severe ankylosing spondylitis and dilated cardiomyopathy (n=1). Extravascular ICD (EV-ICD) implantation was evaluated. Extravascular ICD implantation in a patient with severe ankylosing spondylitis achieved an R-wave sensing amplitude of 5.6 mV, successful 30 J defibrillation, and stable performance at 6 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: